These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3359945)

  • 1. Synovial fluid and plasma kinetics of repeat dose sustained action tiaprofenic acid in patients with rheumatoid arthritis.
    Nichol FE; Samanta A; Rose CM
    Drugs; 1988; 35 Suppl 1():46-51. PubMed ID: 3359945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of prostaglandin E2 concentrations in synovial fluid of patients suffering from rheumatoid arthritis following tiaprofenic acid or indomethacin treatment.
    Daymond TJ; Rowell FJ
    Drugs; 1988; 35 Suppl 1():4-8. PubMed ID: 3162870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Trans-synovial kinetics of tiaprofenic acid].
    Kurowski M
    Z Rheumatol; 1988; 47(3):173-6. PubMed ID: 3213265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
    Scott G; Rordorf C; Reynolds C; Kalbag J; Looby M; Milosavljev S; Weaver M; Huff JP; Ruff DA
    Clin Pharmacokinet; 2004; 43(7):467-78. PubMed ID: 15139795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of tiaprofenic acid and its enantiomers.
    Davies NM
    Clin Pharmacokinet; 1996 Nov; 31(5):331-47. PubMed ID: 9118583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of tiaprofenic acid in normal rabbits and rabbits subjected to joint immobilisation.
    Meyer-Carrive I; Graham GG; Ghosh P
    Agents Actions; 1993 May; 39(1-2):59-68. PubMed ID: 8285141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of sustained release tiaprofenic acid in elderly arthritic patients.
    Hosie GA; Hosie J
    Br J Clin Pharmacol; 1987 Jul; 24(1):93-5. PubMed ID: 3620289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolmetin kinetics and synovial fluid prostaglandin E levels in rheumatoid arthritis.
    Dromgoole SH; Furst DE; Desiraju RK; Nayak RK; Kirschenbaum MA; Paulus HE
    Clin Pharmacol Ther; 1982 Sep; 32(3):371-7. PubMed ID: 7105628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of a sustained release preparation of tiaprofenic acid with the conventional tablet formulation and a placebo in rheumatoid arthritis.
    Essigman W; Lambert J; Sheldon P; Sweetman BJ; Wojtulewski J
    Int J Clin Pharmacol Res; 1987; 7(4):251-7. PubMed ID: 3596867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transsynovial distribution of oxaprozin.
    Kurowski M; Thabe H
    Agents Actions; 1989 Jun; 27(3-4):458-60. PubMed ID: 2801338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of sustained action tiaprofenic acid in elderly arthritic patients.
    Hosie GA; Hosie J
    Drugs; 1988; 35 Suppl 1():52. PubMed ID: 3359946
    [No Abstract]   [Full Text] [Related]  

  • 12. Disappearance kinetics of solutes from synovial fluid after intra-articular injection.
    Owen SG; Francis HW; Roberts MS
    Br J Clin Pharmacol; 1994 Oct; 38(4):349-55. PubMed ID: 7833225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and synovial fluid concentrations of diclofenac sodium and its hydroxylated metabolites during once-daily administration of a 100 mg slow-release formulation.
    Fowler PD; Dawes PT; John VA; Shotton PA
    Eur J Clin Pharmacol; 1986; 31(4):469-72. PubMed ID: 3469101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [6-methoxy-2-naphthylacetic acid level in plasma, synovial fluid and adjacent tissue in patients with rheumatoid arthritis or gonarthroses after a 4-day therapy with nabumetone (Arthaxan)].
    Miehlke RK; Schneider S; Sörgel F; Muth P; Henschke F; Fedder M
    Z Rheumatol; 1991; 50(2):103-8. PubMed ID: 1872041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid.
    Day RO; McLachlan AJ; Graham GG; Williams KM
    Clin Pharmacokinet; 1999 Mar; 36(3):191-210. PubMed ID: 10223168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of etodolac in serum and synovial fluid of patients with arthritis.
    Kraml M; Hicks DR; McKean M; Panagides J; Furst D
    Clin Pharmacol Ther; 1988 May; 43(5):571-6. PubMed ID: 2966693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid.
    Bird HA; Allen JG; Dixon JS; Wright V
    Eur J Rheumatol Inflamm; 1985; 8(1):47-52. PubMed ID: 3879830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid.
    Netter P; Bannwarth B; Royer-Morrot MJ
    Clin Pharmacokinet; 1989 Sep; 17(3):145-62. PubMed ID: 2680211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indomethacin kinetics in synovia and plasma following administration of indomethacin Gits 7/85 in patients with chronic polyarthritis].
    Zöller B; Zimmer M; Dittrich P; Lehmann K; Engel HJ; Faust-Tinnefeldt G; Kukovetz WR
    Z Rheumatol; 1983; 42(2):78-81. PubMed ID: 6880406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of total and unbound concentrations of tenoxicam in synovial fluid and plasma.
    Day RO; Williams KM; Graham S; Handel M
    Arthritis Rheum; 1991 Jun; 34(6):751-60. PubMed ID: 2053921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.